Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

Dienstmann, R.; Mason, M. J.; Sinicrope, F. A.; Phipps, A. I.; Tejpar, S.; Nesbakken, A.; Danielsen, S. A.; Sveen, A.; Buchanan, D. D.; Clendenning, M.; Rosty, C.; Bot, B.; Alberts, S. R.; Jessup, J. Milburn; Lothe, R. A.; Delorenzi, M.; Newcomb, P. A.; Sargent, D.; Guinney, J.

journal article

oai:espace.library.uq.edu.au:UQ:601899

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

Authors: R. Dienstmann
M. J. Mason
F. A. Sinicrope
A. I. Phipps
S. Tejpar
A. Nesbakken
S. A. Danielsen
A. Sveen
D. D. Buchanan
M. Clendenning
C. Rosty
B. Bot
S. R. Alberts
J. Milburn Jessup
R. A. Lothe
M. Delorenzi
P. A. Newcomb
D. Sargent
J. Guinney
Publication date: 1 May 2017
Publisher: 'Oxford University Press (OUP)'
Doi

Abstract

Background: TNM staging alone does not accurately predict outcome in colon cancer (CC) patients who may be eligible for adjuvant chemotherapy. It is unknown to what extent the molecular markers microsatellite instability (MSI) and mutations in BRAF or KRAS improve prognostic estimation in multivariable models that include detailed clinicopathological annotation

Similar works

Full text

UQ eSpace (University of Queensland)

oai:espace.library.uq.edu.au:U...

Last time updated on 01/07/2017

This paper was published in UQ eSpace (University of Queensland).

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.